In the United States there are approximately 36,000 new cases of kidney cancer each year, and 12,000 individuals die from the disease. Kidney cancer is an international disease. New syndromes are being recognized and characterization of the associated symptoms as well as identification of the genes involved in the disease are important to develop appropriate therapies. Continuation of this project is of great importance because, at the moment, there are families with kidney cancer that do not have any of their genetic changes known. Therefore we need to study these families morphologically and genetically, as well as try to identify new proteins useful as tumor markers.
The specific aims of this study are to: 1) Define the types and morphological characteristics of new renal syndromes;2) Identify the genes and molecular changes responsible for these new syndromes;3) Identify genotype/ phenotype correlation;and 4) Study the associated lesions such as uterine and other smooth muscle tumors, skin, lung and ovarian tumors, and investigate if they share similar genetic changes. Continuation of this research is essential;first, because these tumors can only be recognized by their morphology and secondly, because we lack both markers for early detection and good forms of therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC010696-07
Application #
8349107
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2011
Total Cost
$292,616
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Sidana, Abhinav; Kadakia, Meet; Friend, Julia C et al. (2017) Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer. Urol Oncol 35:114.e9-114.e14
Vocke, Cathy D; Ricketts, Christopher J; Merino, Maria J et al. (2017) Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma. Genes Chromosomes Cancer 56:484-492
Bi, Mark; Zhao, Siming; Said, Jonathan W et al. (2016) Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proc Natl Acad Sci U S A 113:2170-5
Linehan, W Marston; Merino, Maria J; Ricketts, Christopher J (2016) Papillary Renal-Cell Carcinoma. N Engl J Med 374:1991
Fascelli, Michele; Rais-Bahrami, Soroush; Sankineni, Sandeep et al. (2016) Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population. Urology 88:125-34
Lang, Martin; Vocke, Cathy D; Merino, Maria J et al. (2015) Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors. Mod Pathol 28:1458-69
Karageorgiadis, Alexander S; Papadakis, Georgios Z; Biro, Juliana et al. (2015) Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab 100:141-8
Zilbermint, Mihail; Xekouki, Paraskevi; Faucz, Fabio R et al. (2015) Primary Aldosteronism and ARMC5 Variants. J Clin Endocrinol Metab 100:E900-9
Shuch, Brian; Vourganti, Srinivas; Ricketts, Christopher J et al. (2014) Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol 32:431-7
Shuch, Brian; Hofmann, Jonathan N; Merino, Maria J et al. (2014) Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol 32:23.e9-13

Showing the most recent 10 out of 48 publications